DHR vs MPLT · P/E 39, rev $6.26B vs $1.24B cap
Danaher Corporation (DHR) versus MapLight Therapeutics, Inc. Common Stock (MPLT) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US. It is led by Rainer M. Blair.
MapLight Therapeutics, Inc. Common Stock (MPLT) is a biotechnology company listed on NASDAQ.
Latest reported DHR revenue for 2026-06-26 was $6.26B. Net income was $870.0M. Revenue was up 5.3% from 2026-03-27 to 2026-06-26. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
MPLT does not have a complete income-statement cache yet.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. MPLT currently screens at market cap $1.24B.
Not investment advice. Open the DHR and MPLT stock pages for the full models.
Not investment advice.